LABT
Lakewood-Amedex Biotherapeutics Inc. Common Stock
NASDAQ: LABT · HEALTHCARE · BIOTECHNOLOGY
$2.95
-4.60% today
Updated 2026-06-02
Market cap
$6.21M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-3.26
Dividend yield
—
52W range
$1 – $10
Volume
2.5M
Lakewood-Amedex Biotherapeutics Inc. Common Stock (LABT) Financial statements
SEC filings — annual and quarterly data.
Balance sheet — annual
| Item |
|---|
| Total assets |
| Cash & equivalents |
| Current assets |
| Total liabilities |
| Current liabilities |
| Long-term debt |
| Shareholder equity |
| Retained earnings |
| Accounts receivable |
| Inventory |
| Goodwill |